20 Stocks Moving In Monday's Pre-Market Session

Gainers

  • AveXis, Inc. AVXS rose 85.1 percent to $214.60 in pre-market trading after the company agreed to be acquired by Novartis AG NVS for $8.7 billion.
  • Therapix Biosciences Ltd. TRPX rose 32.5 percent to $6.60 in pre-market trading after the company disclosed topline results of Phase IIa study at Yale University for Tourette Syndrome program.
  • REGENXBIO Inc. RGNX rose 23 percent to $33.45 in pre-market trading after dropping 3.89 percent on Friday.
  • Verastem, Inc. VSTM shares rose 22.3 percent to $3.62 in pre-market trading after the company disclosed that the FDA has accepted New Drug Application for duvelisib.
  • Cellect Biotechnology Ltd. APOP rose 16.8 percent to $7.58 in pre-market trading after the company reported that it has successfully completed a Proof of Concept study for ApoTainer.
  • Audentes Therapeutics, Inc. BOLD rose 9.8 percent to $30.86 in pre-market trading after dropping 2.87 percent on Friday.
  • Senseonics Holdings, Inc. SENS shares rose 7.5 percent to $4.00 in pre-market trading after gaining 5.68 percent on Friday.
  • Marrone Bio Innovations, Inc. MBII shares rose 7.1 percent to $3.48 in pre-market trading after jumping 21.72 percent on Friday.
  • Portola Pharmaceuticals, Inc. PTLA rose 6.8 percent to $33.00 in pre-market trading after falling 4.01 percent on Friday.
  • JinkoSolar Holding Co., Ltd. JKS rose 6.3 percent to $20.31 in pre-market trading after falling 4.64 percent on Friday.
  • bluebird bio, Inc. BLUE shares rose 5.7 percent to $172 in pre-market trading after falling 4.38 percent on Thursday.
  • Leucadia National Corporation LUK rose 4.4 percent to $22.73 in pre-market trading after the company agreed to sell 48 percent of National Beef for $1.05 billion and its stake in Garcadia for $425 million. The company also announced a 25 million share buyback plan.
  • Deutsche Bank AG (USA) DB shares rose 3.8 percent to $14.40 in pre-market trading after the bank named Christian Sewing as its new CEO. The bank’s new CEO announced plans to review investment banking business.
  • Merck & Co., Inc. MRK rose 3.1 percent to $54.97 in pre-market trading after the company disclosed that its KEYTRUDA monotherapey met its primary endpoint in the Phase 3 KEYNOTE-042 study.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Menlo Therapeutics Inc. MNLO fell 51.7 percent to $17.00 in pre-market trading as the company disclosed that its Phase 2 trial of serlopitant for pruritus associated with atopic dermatitis did not meet primary and key secondary efficacy endpoints.
  • New York Times Company NYT fell 6.8 percent to $22.00 in pre-market trading after rising 2.39 percent on Friday.
  • Broadwind Energy, Inc. BWEN fell 6.3 percent to $2.84 afterclimbing 28.94 percent on Friday.
  • Sibanye Gold Limited SBGL shares fell 6 percent to $3.75 in pre-market trading after rising 3.37 percent on Friday.
  • SSLJ.com Limited SSLJ fell 5.2 percent to $4.93 in pre-market trading after dropping 2.80 percent on Friday.
  • Yandex N.V. YNDX shares fell 4.9 percent to $37.47 in pre-market trading after declining 1.84 percent on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading Ideas#PreMarket GainersFinancialsLosersMulti-Sector HoldingsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!